|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 205.30 PLN | -0.77% |
|
-5.00% | +34.42% |
| 17/07 | Bayer Ag and Henry Ford Health Announce Strategic Research Partnership to Expand Patient Access to Clinical Trials | CI |
| 17/07 | BAYER AG : JP Morgan keeps its Buy rating | ZD |
| Market Cap | 47.61B 54.48B 43.93B 40.49B 76.32B 5,246B 78.02B 525B 207B 2,569B 205B 200B 8,845B | P/E 2026 * |
20.9x | P/E 2027 * | 15.7x |
|---|---|---|---|---|---|
| Enterprise Value | 79.45B 90.91B 73.31B 67.58B 127B 8,755B 130B 876B 345B 4,288B 341B 334B 14,761B | EV / Sales 2026 * |
1.74x | EV / Sales 2027 * | 1.63x |
| Free-Float |
100% | Yield 2026 * |
0.47% | Yield 2027 * | 1.3% |
Last Transcript: Bayer AG
| 1 week | -5.74% | ||
| Current month | +0.88% | ||
| 1 month | +29.90% | ||
| 3 months | +16.61% | ||
| 6 months | +17.35% | ||
| Current year | +33.38% |
| 1 week | 205.3 |  | 216 |
| 1 month | 159.05 | | 230.5 |
| 3 years | 78.97 | | 241 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 59 | 01/06/2023 |
Judith Hartmann
DFI | Director of Finance/CFO | 57 | 01/06/2026 |
Philipp Blank
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
André van Broich
BRD | Director/Board Member | 56 | 01/04/2012 |
Heike Hausfeld
BRD | Director/Board Member | 60 | 01/04/2017 |
| Chairman | 68 | 28/04/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.77% | -5.00% | +75.41% | -10.02% | 53.63B | |
| +0.85% | -0.80% | +54.84% | +163.70% | 1,043B | |
| +1.23% | -1.53% | +55.26% | +59.07% | 602B | |
| +0.04% | +2.58% | +32.96% | +88.75% | 449B | |
| +0.78% | -0.71% | +30.04% | +24.61% | 327B | |
| +1.41% | +0.58% | +33.92% | +47.20% | 279B | |
| -0.27% | -1.87% | +22.13% | +23.47% | 264B | |
| -1.42% | +0.80% | +22.81% | +60.77% | 201B | |
| -1.48% | +3.43% | +23.42% | +73.31% | 169B | |
| -0.36% | +3.64% | +1.91% | -30.15% | 143B | |
| Average | +0.28% | +0.47% | +35.27% | +50.07% | 386.34B | |
| Weighted average by Cap. | +0.40% | -0.13% | +40.57% | +83.06% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 45.6B 52.18B 42.08B 38.79B 73.11B 5,025B 74.73B 503B 198B 2,461B 196B 192B 8,473B | 46.76B 53.5B 43.15B 39.77B 74.96B 5,152B 76.62B 516B 203B 2,523B 201B 197B 8,687B |
| Net income | 2.13B 2.43B 1.96B 1.81B 3.41B 234B 3.48B 23.45B 9.22B 115B 9.14B 8.94B 395B | 2.93B 3.36B 2.71B 2.49B 4.7B 323B 4.81B 32.34B 12.72B 158B 12.6B 12.33B 545B |
| Net Debt | 31.84B 36.44B 29.38B 27.08B 51.05B 3,509B 52.18B 351B 138B 1,719B 137B 134B 5,916B | 28.71B 32.86B 26.49B 24.42B 46.03B 3,164B 47.05B 317B 125B 1,550B 123B 121B 5,334B |
| Date | Price | Change |
|---|---|---|
| 17/07/26 | PLN 205.30 | -0.77% |
| 16/07/26 | PLN 206.90 | -1.71% |
| 15/07/26 | PLN 210.50 | -2.55% |
| 14/07/26 | PLN 216.00 | 0.00% |
| 13/07/26 | PLN 216.00 | -0.83% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BAYN Stock
- BAY Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
